LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.30_32del
PTEN
· NP_000305.3:p.(Ser10del)
· NM_000314.8
GRCh37: chr10:89624253 TAGC>T
·
GRCh38: chr10:87864496 TAGC>T
Gene:
PTEN
Transcript:
NM_000314.8
Final call
VUS
PM6 moderate
PM2 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Ser10del)
gnomAD AF
ClinVar
Uncertain Significance
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, below the 0.001% population frequency threshold.
2
PM6 (Moderate): one ClinVar clinical-laboratory record reports presumed de novo occurrence with a PTEN-consistent phenotype; maternity and paternity are unconfirmed, and possible germline mosaicism is flagged for human review.
3
VUS: PM6 (Moderate) plus PM2 (Supporting) matches no established Pathogenic, Likely Pathogenic, Benign, or Likely Benign combination rule.
Final determination:
Under the ClinGen PTEN Expert Panel Version 3.2 criteria-combination framework, PM6 Moderate plus PM2 Supporting matches no final-classification rule and therefore yields VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: p.(Ser10del) is an in-frame single-codon deletion with no premature stop codon, so no nonsense-mediated decay is predicted. |
cspec
vcep_pvs1_decisiontree_pten
|
| PS1 | N/A | Not applicable: PS1 applies only to amino-acid substitutions, and this variant is an in-frame deletion (p.(Ser10del)). |
cspec
|
| PS2 | Not assessed | Not assessed: confirmed maternity and paternity were not documented, which the PTEN PS2 rule requires for de novo evidence. |
cspec
clinvar
|
| PS3 | Not assessed | Not assessed: no variant-specific result for p.(Ser10del) exists in the Mighell 2018 assay (PS3 requires phosphatase activity <= -1.11). |
cspec
vcep_mmc2
PMID:29706350
|
| PS4 | Not assessed | Not assessed: neither a case-control result (odds ratio >2, p<0.05) nor proband phenotype data reaching the specificity score of 1 was available. |
cspec
clinvar
|
| PM1 | Not met | Not met: residue 10 lies outside the PTEN catalytic motifs (WPD loop 90-94, P-loop 123-130, TI-loop 166-168). |
cspec
PMID:29706350
|
| PM2 | Met | Met (Supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, below the 0.001% population frequency threshold. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM3 | N/A | Not applicable: the PTEN Expert Panel designates PM3 not applicable because PTEN-associated disease is autosomal dominant. |
cspec
|
| PM4 | Not met | Not met: PM4 requires an in-frame indel affecting a catalytic motif; Ser10 is outside motifs 90-94, 123-130, and 166-168. |
cspec
|
| PM5 | N/A | Not applicable: PM5 is restricted to missense substitutions, and this variant is an in-frame deletion (p.(Ser10del)). |
cspec
pm5_candidates
|
| PM6 | Met | Met (Moderate): one ClinVar clinical-laboratory record reports presumed de novo occurrence with a PTEN-consistent phenotype, though maternity and paternity are unconfirmed. Flagged for human review: the record is a secondary submission that mentions possible germline mosaicism. |
cspec
clinvar
|
| PP1 | Not assessed | Not assessed: no family co-segregation data was available (supporting strength requires at least 3 informative meioses). |
cspec
|
| PP2 | N/A | Not applicable: PP2 is restricted to missense variants, and this variant is an in-frame deletion. |
cspec
|
| PP3 | Not assessed | Not assessed: SpliceAI predicts no splice impact (max delta 0.037), but the required concordant VarSeak prediction is unavailable. |
cspec
spliceai
|
| PP4 | N/A | Not applicable: the PTEN Expert Panel folds phenotype specificity into PS4, so PP4 does not apply. |
cspec
|
| PP5 | N/A | Not applicable: the ClinVar expert-panel assertion for this variant is Uncertain Significance, not Pathogenic or Likely Pathogenic. |
cspec
clinvar
|
| BA1 | Not met | Not met: the variant is absent from gnomAD, well below the 0.056% filtering allele frequency required for BA1. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS1 | Not met | Not met: the variant is absent from gnomAD, with no observed frequency in the BS1 range (0.00043%-0.056%). |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS2 | Not assessed | Not assessed: no homozygous observation in a healthy individual was available to support BS2. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS3 | Not assessed | Not assessed: no functional assay result for p.(Ser10del) was available (BS3 would require phosphatase activity >0 in Mighell 2018). |
cspec
vcep_mmc2
PMID:29706350
|
| BS4 | Not assessed | Not assessed: no affected relatives lacking the variant were documented, so lack of segregation could not be established. |
cspec
|
| BP1 | N/A | Not applicable: the PTEN Expert Panel designates BP1 not applicable to PTEN. |
cspec
|
| BP2 | Not assessed | Not assessed: no phase, cis, or trans observations were available to establish BP2. |
cspec
|
| BP3 | N/A | Not applicable: explicitly designated not applicable by the PTEN Expert Panel. |
cspec
|
| BP4 | Not assessed | Not assessed: SpliceAI predicts no splice impact (max delta 0.037), but the required concordant VarSeak result is unavailable. |
cspec
spliceai
|
| BP5 | Not assessed | Not assessed: no evidence of two affected cases with a separate highly penetrant molecular diagnosis was available. |
cspec
clinvar
|
| BP6 | N/A | Not applicable: the ClinVar expert-panel assertion for this variant is Uncertain Significance, not Benign or Likely Benign. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: BP7 applies only to synonymous or intronic variants, and this is an exonic in-frame deletion. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.